109 related articles for article (PubMed ID: 20205955)
1. Functional significance of the hepaCAM gene in bladder cancer.
He Y; Wu X; Luo C; Wang L; Lin J
BMC Cancer; 2010 Mar; 10():83. PubMed ID: 20205955
[TBL] [Abstract][Full Text] [Related]
2. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells.
Wang Q; Luo C; Wu X; Du H; Song X; Fan Y
J Urol; 2013 Nov; 190(5):1912-8. PubMed ID: 23669565
[TBL] [Abstract][Full Text] [Related]
3. [Construction of deltaNp63 specific small hairpin RNA expressing plasmid and its role in bladder cancer--a preliminary study].
He YF; Wu XH; Luo CL; Tian DY; Zhang LS; Gao F
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):820-5. PubMed ID: 17416002
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma.
Chung Moh M; Hoon Lee L; Shen S
J Hepatol; 2005 Jun; 42(6):833-41. PubMed ID: 15885354
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma, and the interferon-γ mechanism inhibiting BIU-87 proliferation.
Xu B; He Y; Wu X; Luo C; Liu A; Zhang J
J Urol; 2012 Oct; 188(4):1346-53. PubMed ID: 22906662
[TBL] [Abstract][Full Text] [Related]
6. [Influence of hepatocyte cell adhesion molecule on gene expression profile of human bladder transitional cell carcinoma cell line].
Wang QJ; Lv CK; Tao J; Du HF; Fan YR; Song XD; Luo CL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):190-8. PubMed ID: 23643009
[TBL] [Abstract][Full Text] [Related]
7. Exon 2 methylation inhibits hepaCAM expression in transitional cell carcinoma of the bladder.
Pan C; Wu X; Luo C; Yang S; Pu J; Wang C; Shen S
Urol Int; 2010; 85(3):347-54. PubMed ID: 20628239
[TBL] [Abstract][Full Text] [Related]
8. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
Guo B; Luo C; Xun C; Xie J; Wu X; Pu J
Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
Moh MC; Zhang T; Lee LH; Shen S
Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
[TBL] [Abstract][Full Text] [Related]
10. 5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.
Wang X; Chen E; Yang X; Wang Y; Quan Z; Wu X; Luo C
Oncol Rep; 2016 Mar; 35(3):1375-84. PubMed ID: 26677113
[TBL] [Abstract][Full Text] [Related]
11. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
Zhang H; Jiang H; Wang W; Gong J; Zhang L; Chen Z; Ding Q
Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
[TBL] [Abstract][Full Text] [Related]
12. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
13. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional analyses of a novel ig-like cell adhesion molecule, hepaCAM, in the human breast carcinoma MCF7 cells.
Moh MC; Zhang C; Luo C; Lee LH; Shen S
J Biol Chem; 2005 Jul; 280(29):27366-74. PubMed ID: 15917256
[TBL] [Abstract][Full Text] [Related]
15. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.
Maas S; Warskulat U; Steinhoff C; Mueller W; Grimm MO; Schulz WA; Seifert HH
Urology; 2004 Feb; 63(2):392-7. PubMed ID: 14972509
[TBL] [Abstract][Full Text] [Related]
16. c-Jun is involved in interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human bladder cancer T24 cells.
Li Z; Zhu Y; Yu M; Ji D; Yang Z; Kong C
Urol Oncol; 2013 Feb; 31(2):228-33. PubMed ID: 21872498
[TBL] [Abstract][Full Text] [Related]
17. Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.
Zhang N; Ye L; Wu L; Deng X; Yang Y; Jiang WG
Anticancer Res; 2013 May; 33(5):1917-25. PubMed ID: 23645739
[TBL] [Abstract][Full Text] [Related]
18. Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer.
Watson CJ; O'Kane H; Maxwell P; Sharaf O; Petak I; Hyland PL; O'Rouke D; McKnight J; Canning P; Williamson K
Int J Oncol; 2012 Mar; 40(3):645-54. PubMed ID: 22076446
[TBL] [Abstract][Full Text] [Related]
19. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
20. Dual role of TGFBR3 in bladder cancer.
Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
